Roche Holding Ltd. (VTX:ROG) has been given a CHF 279 target price by analysts at Liberum Capital in a research note issued to investors on Wednesday. The brokerage currently has a “buy” rating on the healthcare company’s stock. Liberum Capital’s price target would suggest a potential upside of 13.09% from the stock’s current price.

Other analysts have also issued reports about the stock. J P Morgan Chase & Co reiterated a “buy” rating and issued a price target on shares of Roche Holding in a research note on Friday, July 28th. Sanford C. Bernstein set a CHF 284 price target on shares of Roche Holding and gave the stock a “buy” rating in a research note on Thursday, July 27th. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on shares of Roche Holding and gave the stock a “buy” rating in a research note on Thursday, August 24th. Berenberg Bank set a CHF 273 price target on shares of Roche Holding and gave the stock a “buy” rating in a research note on Tuesday, August 15th. Finally, Credit Suisse Group set a CHF 300 price objective on shares of Roche Holding and gave the stock a “buy” rating in a report on Monday, September 11th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of CHF 261.78.

Shares of Roche Holding (VTX:ROG) opened at CHF 246.70 on Wednesday. Roche Holding has a 12 month low of CHF 218.30 and a 12 month high of CHF 273.

COPYRIGHT VIOLATION NOTICE: “Roche Holding Ltd. (ROG) PT Set at CHF 279 by Liberum Capital” was posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/11/22/roche-holding-ltd-rog-pt-set-at-chf-279-by-liberum-capital.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.